These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 1945777)
1. [Fundamental and clinical studies of preoperative radiotherapy with high-dose rate intraluminal brachytherapy]. Kamikonya N Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Aug; 51(8):950-61. PubMed ID: 1945777 [TBL] [Abstract][Full Text] [Related]
2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
3. [Results of preoperative high-dose-rate intraluminal brachytherapy for resectable rectal cancer]. Kamikonya N; Izumi M; Tusboi K; Nogi K; Miyamoto Y; Nakao N Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Aug; 58(9):503-8. PubMed ID: 9778936 [TBL] [Abstract][Full Text] [Related]
4. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes? Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365 [TBL] [Abstract][Full Text] [Related]
6. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens. Klenova A; Parvanova V; Georgiev R; Gesheva N J BUON; 2006; 11(2):161-6. PubMed ID: 17318965 [TBL] [Abstract][Full Text] [Related]
7. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780 [TBL] [Abstract][Full Text] [Related]
8. Short versus conventional preoperative radiotherapy of rectal cancer: indications. Klenova A; Georgiev R; Kurtev P; Kurteva G J BUON; 2007; 12(2):227-32. PubMed ID: 17600877 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma. Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654 [TBL] [Abstract][Full Text] [Related]
10. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy. Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405 [TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
12. High-dose-rate intraluminal brachytherapy for postoperative residual tumor of gallbladder carcinoma: a case report. Kurisu K; Hishikawa Y; Taniguchi M; Kamikonya N; Miura T; Kanno H; Okamoto E Radiat Med; 1991; 9(6):241-3. PubMed ID: 1823398 [TBL] [Abstract][Full Text] [Related]
13. Method of determining the treatment volume of high-dose-rate intraluminal brachytherapy (HDRIBT) for rectal cancer by endoscope and simulator. Kamikonya N; Hishikawa Y; Kurisu K; Taniguchi M; Miura T Radiat Med; 1991; 9(4):146-7. PubMed ID: 1961939 [TBL] [Abstract][Full Text] [Related]
14. Preoperative chemotherapy and radiotherapy for locally advanced rectal cancer. Chao M; Gibbs P; Tjandra J; Cullinan M; McLaughlin S; Faragher I; Skinner I; Jones I ANZ J Surg; 2005 May; 75(5):286-91. PubMed ID: 15932438 [TBL] [Abstract][Full Text] [Related]
15. Transabdominal transanal resection of distal rectal cancer after high dose preoperative radiotherapy: a Chinese experience in preserving sphincter function. Zhou JN; Wang DZ; Huang XE; Xu FP; Shang JQ; Gu RM Isr Med Assoc J; 2006 Oct; 8(10):675-8. PubMed ID: 17125111 [TBL] [Abstract][Full Text] [Related]
16. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer. Hiratsuka J; Jo Y; Yoshida K; Nagase N; Fujisawa M; Imajo Y Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):684-90. PubMed ID: 15183471 [TBL] [Abstract][Full Text] [Related]
17. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer. Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017 [TBL] [Abstract][Full Text] [Related]
18. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy. Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536 [TBL] [Abstract][Full Text] [Related]
19. High dose rate brachytherapy as a boost after preoperative chemoradiotherapy for more advanced rectal tumours: the Clatterbridge experience. Sun Myint A; Lee CD; Snee AJ; Perkins K; Jelley FE; Wong H Clin Oncol (R Coll Radiol); 2007 Nov; 19(9):711-9. PubMed ID: 17884396 [TBL] [Abstract][Full Text] [Related]
20. High-dose-rate remote afterloading intestinal radiotherapy employing the template technique for recurrent cancer in the pelvic area. Yamazaki H; Inoue T; Ikeda H; Tang JT; Murayama S; Teshima T; Otani M; Kozuka T Strahlenther Onkol; 1993 Aug; 169(8):481-5. PubMed ID: 8356507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]